The increasing pet arthritis market value demonstrates the rapid transformation occurring within the global veterinary healthcare industry. Osteoarthritis has become one of the leading chronic conditions affecting companion animals, particularly aging dogs and cats. As pet owners continue to prioritize animal wellness and long-term healthcare, demand for innovative arthritis treatments and orthopedic therapies is increasing significantly.
According to Polaris Market Research, the global companion animal osteoarthritis market reached USD 2.26 billion in 2024 and is projected to grow to USD 18.45 billion by 2034 at a CAGR of 23.4%. This rapid expansion reflects increasing investments in veterinary medicine, regenerative therapies, and chronic pain management solutions for pets.
The rising pet arthritis market value is strongly connected to the growing humanization of pets. Modern pet owners increasingly view animals as family members and are willing to spend more on preventive healthcare, advanced diagnostics, rehabilitation therapies, and specialized treatments. This behavioral shift is encouraging veterinary clinics and pharmaceutical companies to expand their osteoarthritis treatment offerings.
Biologics have emerged as one of the fastest-growing product categories in the companion animal osteoarthritis market. The biologics segment accounted for approximately 54% of market revenue in 2024 due to its ability to target inflammation and tissue damage directly. Therapies such as stem cells, platelet-rich plasma, and monoclonal antibodies are providing improved long-term outcomes for animals suffering from joint degeneration.
Canine animals represented the largest revenue share in 2024 because osteoarthritis is highly common among large-breed and aging dogs. Veterinarians are increasingly recommending mobility treatments, joint supplements, pain management solutions, and physical rehabilitation programs to improve canine mobility and quality of life.
The increasing pet arthritis market value is also supported by improvements in veterinary diagnostics. Advanced imaging technologies allow veterinarians to identify osteoarthritis at earlier stages, enabling faster intervention and more effective disease management. Early diagnosis increases demand for ongoing treatment plans, prescription medications, and rehabilitation services.
Read More @ https://www.polarismarketresearch.com/industry-analysis/companion-animal-osteoarthritis-market
Injectable therapies accounted for the largest revenue share in 2024 due to their rapid therapeutic effects and long-lasting pain relief. Injectable regenerative therapies are particularly effective in moderate and severe osteoarthritis cases where traditional oral medications may not provide sufficient symptom control.
Veterinary hospitals and clinics held the largest market share in 2024 because they remain the primary centers for diagnosis, prescription, and administration of osteoarthritis therapies. These facilities increasingly offer advanced orthopedic procedures, biologic injections, rehabilitation programs, and physiotherapy services for companion animals.
North America accounted for the largest share of the companion animal osteoarthritis market in 2024 due to high pet healthcare spending and advanced veterinary infrastructure. Strong awareness regarding chronic joint conditions and widespread adoption of premium veterinary services continue to support market growth across the region.
Europe is also experiencing steady market expansion due to growing emphasis on geriatric pet care and companion animal wellness. Meanwhile, Asia Pacific is expected to witness significant growth between 2025 and 2034 as pet ownership rates increase and veterinary healthcare systems continue developing rapidly.
The expansion of e-commerce platforms is further contributing to rising pet arthritis market value. Online pharmacies and digital healthcare platforms are improving access to medications, nutritional supplements, and mobility products for pet owners worldwide. The convenience of home delivery and subscription-based treatment programs is increasing long-term customer engagement.
As veterinary medicine becomes increasingly advanced and accessible, the pet arthritis market value is expected to continue growing substantially. Rising investment in biologics, regenerative medicine, orthopedic treatments, and pet wellness services will likely shape the future of the global companion animal osteoarthritis market.
More Trending Latest Reports By Polaris Market Research:
U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market
Industrial Microbiology Testing Services Market
G-Protein Coupled Receptors Market
Plastic Welding Equipment Market
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek